The relationship between ideal body weight and ropivacaine lumbar dose in combined epidural and spinal anesthesia for cesarean delivery: a clinical observational study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037861

Enrollment

Unknown

Registered

2020-09-02

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal caesarean section

Interventions

1:0.2mg/kg

2:0.25mg/kg

3:0.3mg/kg

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women with single birth; 2. Subjects with 36-41 weeks of intrauterine pregnancy; 3. Subjects of ASA grade I ~ II; 4. Subjects aged 20-35 years.

Exclusion criteria

Exclusion criteria: 1. Patients allergic to local anesthetics; 2. Patients with coagulation dysfunction; 3. Patients with eclampsia; 4. The objects of hypertension; 5. Patients with central system diseases and cardiac history; 6. Contraindications of intraspinal anesthesia.

Design outcomes

Primary

Measure	Time frame
5 min blocking plane and highest blocking plane;15 min blocking plane and highest blocking plane;Incidence of remediation;Incidence of hypotension;Deoxynorepinephrine treatment rate;	—

Countries

China

Contacts

Public ContactGong Ting

Xiangyang First people's Hospital Affiliated to Hubei Medical University

gt1275886591@outlook.com+86 15072229677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026